{"transactions":[{"id":1530721,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":91588,"kind":"person","name":"Mirza Nadeem Q.","position":1,"cik":"0002021015","reported_name":"Mirza Nadeem Q.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Purchase)","published_at":"2024-05-02T16:16:29.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":26920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4). Twenty-five percent of these options vest on May 1, 2025, with the remaining options vesting ratably over the following 36 months, subject to the Reporting Person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions."}],"balance_after":26920,"derivative":{"exercise_price":5.25,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":29920},"source":{"system":"sec-edgar","filing":"0001104659-24-056402","document":"tm2413094-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021015/000110465924056402/tm2413094-2_4seq1.xml","form_type":"4"}},{"id":1530720,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":91588,"kind":"person","name":"Mirza Nadeem Q.","position":1,"cik":"0002021015","reported_name":"Mirza Nadeem Q.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-05-02T16:16:29.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":6730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4). These shares represent restricted stock units (\"RSUs\") and shall vest and be settled in the Issuer's common stock, on a one-for-one basis in three (3) equal annual installments beginning on May 1, 2025, until vested in full, subject to the Reporting Person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions."}],"balance_after":6730,"source":{"system":"sec-edgar","filing":"0001104659-24-056402","document":"tm2413094-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021015/000110465924056402/tm2413094-2_4seq1.xml","form_type":"4"}}]}